Access the full text.
Sign up today, get DeepDyve free for 14 days.
(1973)
The effects of pimozide on sleep in the rat. Paper presented at the Meeting of the Association for the Psychophysiological Study
B. Brodie, M. Comer, E. Costa, A. Dlabač (1966)
The role of brain serotonin in the mechanism of the central action of reserpine.The Journal of pharmacology and experimental therapeutics, 152 2
D. Dunleavy, Vlasta Březinová, Ian Oswald, A. Maclean, M. Tinker (1972)
Changes During Weeks in Effects of Tricyclic Drugs on the Human Sleeping BrainBritish Journal of Psychiatry, 120
M. Jouvet (1969)
Biogenic amines and the states of sleep.Science, 163 3862
A. Kales, R. Ansel, C. Markham, M. Scharf, T. Tan (1971)
Sleep in patients with Parkinson's disease and normal subiects prior to and following levodopa administrationClinical Pharmacology & Therapeutics, 12
M. Stern, H. Roffwarg, R. Duvoisin (1968)
THE PARKINSONIAN TREMOR IN SLEEPThe Journal of Nervous and Mental Disease, 147
William Dement, Nathaniel Kleitman (1957)
Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming.Electroencephalography and clinical neurophysiology, 9 4
(1965)
Etude electrophysiologique et neuropharmacologique des 6tats de sommeil
R. Wyatt, V. Zarcone, K. Engelman, W. Dement, F. Snyder, A. Sjoerdsma (1971)
Effects of 5-hydroxytryptophan on the sleep of normal human subjects.Electroencephalography and clinical neurophysiology, 30 6
R. Wyatt, T. Chase, Jimmy Scott, F. Snyder, Karl Engleman (1970)
Effect of L-Dopa on the Sleep of ManNature, 228
Robert Williams, Harman Agnew, Wilse Webb (1964)
SLEEP PATTERNS IN YOUNG ADULTS: AN EEG STUDY.Electroencephalography and clinical neurophysiology, 17
R. Wyatt, T. Chase, D. Kupfer, Jimmy Scott, F. Snyder, A. Sjoerdsma, K. Engelman (1971)
Brain Catecholamines and Human SleepNature, 233
Richard Wyatt, Karl Engelman, DavidJ Kupfer, Jimmy Scott, Albert Sjoerdsma, Frederick Snyder (1969)
Effects of para-chlorophenylalanine on sleep in man.Electroencephalography and clinical neurophysiology, 27 5
S. Lewis, J. Evans (2005)
Dose effects of chlorpromazine on human sleepPsychopharmacologia, 14
P. Janssen, W. Soudijn, I. Wijngaarden, A. Dresse (1968)
Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. 3. Regional distribution of pimozide and of haloperidol in the dog brain.Arzneimittel-Forschung, 18 3
G. Klem, H. Lüders, H. Jasper, C. Elger (1999)
The ten-twenty electrode system of the International Federation. The International Federation of Clinical Neurophysiology.Electroencephalography and clinical neurophysiology. Supplement, 52
Yamamoto Kjen-Ichi, Edward Domino (1967)
Cholinergic agonist-antagonist interactions on neocortical and limbic EEG activation.International journal of neuropharmacology, 6 5
W. Janke, G. Debus (1972)
Double-blind Psychometric Evaluation of Pimozide and Haloperidol versus Placebo in Emotionally labile Volunteers under two Different Work Load ConditionsPharmacopsychiatrie, 5
J. Hoffman, E. Domino (1969)
Comparative effects of reserpine on the sleep cycle of man and cat.The Journal of pharmacology and experimental therapeutics, 170 2
(1966)
Effets des 16sions du systtme du raph6 sur le sommeil et la strotonine ctrtbrale
N. Andén, Sherrel Butcher, H. Corrodi, K. Fuxe, Urban Ungerstedt (1970)
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.European journal of pharmacology, 11 3
R. George, W. Haslett, D. Jenden (1964)
A CHOLINERGIC MECHANISM IN THE BRAINSTEM RETICULAR FORMATION: INDUCTION OF PARADOXICAL SLEEP.International journal of neuropharmacology, 3
T. Sagalés, S. Erill, E. Domino (1969)
Differential effects of scopolamine and chlorpromazine on REM and NREM sleep in normal male subiectsClinical Pharmacology & Therapeutics, 10
213 41 41 1 1 Teresa Sagalés Sergio Erill Servicio de Electroencefalografía y Neurofisiología Clínica Ciudad Sanitaria de la Seguridad Social Spain Departamento de Farmacología Universidad Autónoma de Barcelona Spain Abstract The effect of pimozide, a potent and specific blocker of central dopaminergic transmission, upon the sleep of man was studied in six healthy volunteers. Given at doses of 1 and 4 mg, which have clear central effects in humans, pimozide produced only minor changes in the EEG patterns of sleep. At these doses a slight and non-significant decrease in phase I sleep was observed, while phases W, II, III, IV and REM were not modified. No differences were noted between drug or post-treatment and control nights in total NREM sleep, total REM sleep, number of episodes of REM or total number of eye movements. An increase in REM sleep in the first third of the second pimozide night and an increase in the duration of the first REM period in the first drug night were the only statistically significant findings. If one accepts that central effects seen in man after pimozide given in conditions similar to those of this study are due to dopaminergic blockade, our results tend to suggest that dopamine is, at most, of rather minor importance in the physiology of sleep in man.
Psychopharmacology – Springer Journals
Published: Jan 1, 1975
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.